At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Intranasal Steroid for Children With Sleep-Disordered Breathing Non-Responsive to Initial Treatment With Intranasal Saline: A Randomized Trial
In Brief
A Phase 4 clinical trial evaluating Mometasone Furoate 50mcg Nasal Spray and Sodium Chloride 0.9 % Nasal Spray for Sleep Disorder; Breathing-Related and 5 related conditions. Completed, enrolled 130 participants across 2 sites.
Detailed Summary
MIST+ is studying a nasal spray to see if it will reduce the need for surgery for snoring. Children aged 3-12 are invited to take part. Snoring affects up to 10% of children and can cause sleeping problems and concentration or behavioural issues in the daytime. Currently the most common treatment for snoring is surgery to remove the tonsils and/or adenoids, however many children wait a long time to see a specialist. This research is trying to find if nasal sprays can help children with snoring, and whether this can reduce the need for surgery.
Study Details
Timeline
Interventions
Intranasal steroid (Mometasone Furoate 50mcg) one spray each nostril daily for 6 weeks
Intranasal saline spray (Sodium Chloride 0.9%) one spray each nostril daily for 6 weeks